1 Yadav D, Yadav SK, Khar RK, et al. Turmeric(Curcuma longa L.): A promising spice for phytochemical and pharmacological activities[J]. Int J Green Pharmacy, 2013, 7(2): 9-85.
2 Singh S. From exotic spice to modern drug?[J]. cell, 2007, 130(5): 765-768.
3 Kunnumakkara AB, Bordoloi D, Padmavathi G, et al. Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases[J]. Br J Pharmacol, 2017, 174(11): 1325-1348.
4 Yu X, Yu S, Chen L, et al. Tetrahydroberberrubine attenuates lipopolysaccharide-induced acute lung injury by down-regulating MAPK, AKTand NF-κappa B signaling pathways[J]. Biomed Pharmacother, 2016, 82: 489-497.
5 Faller S, Strosing KM, Ryter SW, et al.The volatile anesthetic isoflurane prevents ventilator-induced lung injury via phosphoinositide 3-kinase/Akt signaling in mice[J]. Anesth Analg, 2012, 114(4): 747-756.
6 Cheifetz IM. Year in review 2015: Pediatric ARDS[J]. Respir Care,2016, 61(7): 980-985.
7 Ding Q, Liu GQ, Zeng YY, et al. Role of IL-17 in LPS-induced acute lung injury: An in vivo study[J]. Oncotarget, 2017, 8(55): 93704-11.
8 Wang X, Song S, Hu Z, et al. Activation of Epac alleviates inflammation and vascular leakage in LPS-induced acute murine lung injury[J]. Biomed Pharmacother, 2017, 96: 1127-36.
9 Matthay MA, Ware LB, Zimmerman GA. The acute respiratory distress syndrome[J]. Clin Invest, 2012, 122(8): 2731-2740.
10 Zhang Y, Liu Z, Wu J, et al. New MD2 inhibitors derived from curcumin with improved anti-inflammatory activity[J]. Eur J Med Chem, 2018, 148: 291-305.
11 Chai YS, Chen YQ, Lin SH, et al. Curcumin regulates the differentiation of naïve CD4+ T cells and activates IL-10 immune modulation against acute lung injury in mice[J]. Biomed Pharmacother, 2020, 125: 109946.
12 Cheng K, Yang A, Hu X, et al. Curcumin attenuates pulmonary inflammation in lipopolysaccharide induced acute lung injury in neonatal rat model by activating peroxisome proliferator-activated receptor γ(PPARγ)pathway[J]. Med Sci Monit, 2018, 24: 1178-1184.
13 Tsoyi K, Jang HJ, Nizamutdinova IT, et al. Metformin inhibits HMGB1 release in LPS-treated RAW 264.7 cells and increases survival rate of endotoxaemic mice[J]. Br J Pharmacol, 2011, 162(7): 1498-508.
14 Bae HB, Zmijewski JW, Deshane JS, et al. AMP-activated protein kinase enhances the phagocytic ability of macrophages and neutrophils[J]. FASEB J, 2011, 25(12): 4358-368.
15 Zhao X, Zmijewski JW, Lorne E, et al. Activation of AMPK attenuates neutrophil proinflammatory activity and decreases the severity of acute lung injury[J]. Am J Physiol Lung Cell Mol Physiol, 2008, 295(3): L497-504.
16 Towler MC, Hardie DG. AMP-activated protein kinase in metabolic control and insulin signaling[J]. Circ Res, 2007, 100(3): 328-341.
17 Wang S, Song P, Zou MH. AMP-activated protein kinase, stress responses and cardiovascular diseases[J]. Clin Sci(Lond), 2012, 122(12): 555-573.
18 Ji G, Zhang Y, Yang Q, et al. Genistein suppresses LPS-induced inflammatory response through inhibiting NF-κB following AMP kinase activation in RAW 264.7 macrophages[J]. PLoS One, 2012, 7(12): e53101.
19 Kim J, Jeong SW, Quan H, et al. Effect of curcumin(Curcuma longa extract)on LPS-induced acute lung injury is mediated by the activation of AMPK[J]. J Anesth, 2016, 30(1): 100-108.
20 Xu F, Diao R, Liu J, et al. Curcumin attenuates staphylococcus aureus-induced acute lung injury[J]. Clin Respir J, 2015, 9(1): 87-97.
21 Xu Y, Liu L. Curcumin alleviates macrophage activation and lung inflammation induced by influenza virus infection through inhibiting the NF-κB signaling pathway[J]. Influenza Other Respir Viruses, 2017, 11(5): 457-463.
22 Sun J, Yang D, Li S, et al. Effects of curcumin or dexamethasone on lung ischaemia-reperfusion injury in rats[J]. Eur Respir J, 2009, 33(2): 398-404.
23 Sun J, Guo W, Ben Y, et al. Preventive effects of curcumin and dexamethasone on lung transplantation-associated lung injury in rats[J]. Crit Care Med, 2008, 36(4): 1205-1213.
24 Wang X, An X, Wang X, et al. Curcumin ameliorated ventilator-induced lung injury in rats[J]. Biomed Pharmacother, 2018, 98: 754-761.
25 EliasJA, LeeCG, ZhengT, et al. New insights into the pathogenesis of asthma[J]. J Clin Invest, 2003, 111(3): 291-297.
26 Compalati E, Braido F, Canonica GW. An update on allergen immunotherapy and asthma[J]. Curr Opin Pulm Med, 2014, 20(1): 109-117.
27 Zhu T, Zhang W, Wang DX, et al. Rosuvastatin attenuates mucus secretion in a murine model of chronic asthma by inhibiting the gamma-aminobutyric acid type a receptor[J]. Chin Med J, 2012, 125(8): 1457-1464.
28 Gavino AC, Nahmod K, Bharadwaj U, et al. STAT3 inhibition prevents lung inflammation, remodeling, and accumulation of Th2 and Th17 cells in a murine asthma model[J]. Allergy, 2016, 71(12): 1684-1692.
29 Kumari A, Singh DK, Dash D, et al. Intranasal curcumin protects against LPS-induced airway remodeling by modulating toll-like receptor-4(TLR-4)and matrixmetalloproteinase-9(MMP-9)expression via affecting MAP kinases in mouse model[J]. Inflammo Pharma Cology, 2019, 27(4): 731-748.
30 Yang X, Lv JN, Li H, et al. Curcumin reduces lung inflammation via wnt/β-catenin signaling in mouse model of asthma[J]. J Asthma, 2017, 54(4): 335-340.
31 Zhu T, Chen ZH, Chen GH, et al. Curcumin attenuates asthmatic airway inflammation and mucus hypersecretion involving a PPARγ-dependent NF-κB signaling pathway in vivo and in vitro[J]. Mediators Inflamm, 2019: 4927430.
32 Chong L, Zhang W, Nie Y, et al. Protective effect of curcumin on acute airway inflammation of allergic asthma in mice through Notch1-GATA3 signaling pathway[J]. Inflammation, 2014, 37(5): 1476-1485.
33 Brewer JM, Conacher M, Hunter CA. Aluminium hydroxide adjuvantinitiates strong antigen-specific Th2 responses in the absence of IL-4-orIL-13-mediated signaling[J]. J Immunol, 1999, 163(12): 6448-6454.
34 Ma CH, Ma ZQ, Fu Q, et al. Curcumin attenuates allergic airway inflammation by regulation of CD4+ CD25+ regulatory T cells(Tregs)/Th17 balance in ovalbumin-densitized Mice[J]. Fitoterapia, 2013, 87: 57-64.
35 ConroyDM, Williams TJ. Eotaxin and the attraction of eosinophils to the asthmatic lung[J]. Respir Res, 2001, 2(3): 150-156.
36 AcevesSS, Newbury RO, Dohil MA, et al. A symptom scoring tool for identifying pediatric patients with eosinophilic esophagitis and correlating symptoms with inflammation[J]. Ann Allergy Asthma Immunol, 2009, 103(5): 401-406.
37 Bodas M, Patel N, Silverberg D, et al. Master autophagy regulator Transcription factor-EB(TFEB)regulatescigarette smoke induced autophagy-impairment and COPD-emphysema pathogenesis[J]. Antioxid Redox Signal, 2017, 27(3): 150-167.
38 Wu S, Xiao D. Effect of curcumin on nasal symptoms and airflow in patients withperennial allergic rhinitis[J]. Ann Allergy Asthma Immunol, 2016, 117(6): 697-702.
39 Dhillon B, Aggarwal BB, Newman RA, et al. Phase Ⅱ trial of curcumin in patients with advanced pancreatic cancer[J]. Clin Cancer Res, 2008, 14(14): 4491-4499.
40 Chuang EY, Lin KJ, Huang TY, et al. An intestinal “Transformers” -like nanocarrier system for enhancing the oral bioavailability of poorly water-soluble drugs[J]. ACS Nano, 2018, 12(7): 6389-6397.